Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Endocrinol (Copenh) ; 111(4): 452-9, 1986 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3705884

RESUMO

Thirty-five women with prolactinoma have been investigated during 41 pregnancies and 35 lactation periods. Nine of the women had a macroadenoma; 4 of them underwent transsphenoidal microsurgery and one was treated with external pituitary irradiation before pregnancy. All nine were given bromocriptine to induce ovulation. Four women with a microadenoma became pregnant without medical treatment, one shortly after pituitary microsurgery. The other 22 women were treated with bromocriptine only for varying periods before conception. Tumour complications developed in 7 women (20%); 3 had signs of optical nerve compression and 4 showed increased sella volume after pregnancy. All women with tumour complications had been treated with bromocriptine for less than 12 months before conception. Serum prolactin (Prl) was measured every four weeks during pregnancy and after cessation of lactation. In contrast to normal pregnancy, the mean serum Prl did not increase during the second and third trimester of pregnancy in women with pretreatment serum Prl levels above 60 micrograms/l. The lactation period did not have any harmful influence on tumour development. It is concluded that neither pretreatment serum Prl nor radiological changes of the sella turcica can predict tumour development during pregnancy. Treatment with bromocriptine for more than 12 months before conception seems to reduce the risk of tumour progress.


Assuntos
Adenoma/metabolismo , Lactação , Neoplasias Hipofisárias/metabolismo , Complicações Neoplásicas na Gravidez/metabolismo , Prolactina/sangue , Adenoma/terapia , Adulto , Feminino , Seguimentos , Humanos , Neoplasias Hipofisárias/terapia , Gravidez , Complicações Neoplásicas na Gravidez/terapia , Prolactina/metabolismo
4.
Acta Chir Scand ; 145(6): 405-8, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-525186

RESUMO

Diarrhea is a drawback in all types of small intestinal bypass operations for the treatment of morbid obesity. One of the causes of diarrhea is excessive amounts of bile acids in the colon. Therefore in five obese subjects, we complemented the usual jejuno-ileostomy end to side procedure with an anastomosis between the proximal end of the excluded blind loop and the gallbladder (bilio-intestinal shunt). In this way the enterohepatic circulation of bile acids is assumed to be preserved. The patients, subjected to this new methods, were compared to matched patients (age, sex, height, preoperative body-weight, Brocas index and total small intestinal length) following four other types of jejuno-ileostomies. The frequency of diarrhea in the subjects with the bilio-intestinal shunt was significantly less than in the other groups. Other parameters, such as rate and magnitude of weight reduction, changes in blood cholesterol and triglycerides, were the same in the control groups.


Assuntos
Vesícula Biliar/cirurgia , Jejuno/cirurgia , Obesidade/terapia , Adulto , Colesterol/sangue , Diarreia/etiologia , Diarreia/prevenção & controle , Circulação Êntero-Hepática , Feminino , Humanos , Íleo/cirurgia , Métodos , Projetos Piloto , Complicações Pós-Operatórias/prevenção & controle , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...